Insight Molecular Diagnostics Inc (IMDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,789 | -5,300 | 3,033 | -72,902 | -27,924 |
| Depreciation Amortization | 1,355 | 929 | 472 | 23,916 | 3,954 |
| Accounts receivable | 130 | 296 | 111 | -575 | -553 |
| Accounts payable and accrued liabilities | -4,193 | -4,319 | -2,662 | 297 | 422 |
| Other Working Capital | -3,461 | -3,574 | -1,965 | -1,942 | -1,032 |
| Other Operating Activity | -943 | -3,164 | -7,289 | 5,638 | -10,787 |
| Operating Cash Flow | $-18,901 | $-15,132 | $-8,300 | $-45,568 | $-35,920 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 337 | 123 | N/A | -4,340 | -3,538 |
| Net Acquisitions | N/A | N/A | -1,372 | N/A | N/A |
| Other Investing Activity | -1,372 | -1,372 | 0 | 0 | 0 |
| Investing Cash Flow | $-1,035 | $-1,249 | $-1,372 | $-4,340 | $-3,538 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -87 | -57 | -28 | -1,429 | -1,329 |
| Common Stock Issued | 13,848 | 13,848 | N/A | 32,843 | 32,843 |
| Common Stock Repurchased | -1,118 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -427 | -1,545 | 0 | 4,392 | 4,392 |
| Financing Cash Flow | $12,216 | $12,246 | $-28 | $35,806 | $35,906 |
| Beginning Cash Position | 23,203 | 23,203 | 23,203 | 37,305 | 37,305 |
| End Cash Position | 15,483 | 19,068 | 13,503 | 23,203 | 33,753 |
| Net Cash Flow | $-7,720 | $-4,135 | $-9,700 | $-14,102 | $-3,552 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,901 | -15,132 | -8,300 | -45,568 | -35,920 |
| Capital Expenditure | -17 | N/A | N/A | -4,340 | -3,538 |
| Free Cash Flow | -18,918 | -15,132 | -8,300 | -49,908 | -39,458 |